Susquehanna International Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $152M | Sell |
996,400
-577,600
| -37% | -$88.5M | 0.02% | 622 |
|
|
2025
Q4 | $217M | Buy |
1,574,000
+340,600
| +28% | +$44.6M | 0.03% | 509 |
|
|
2025
Q3 | $158M | Buy |
1,233,400
+192,100
| +18% | +$23.4M | 0.02% | 635 |
|
|
2025
Q2 | $126M | Sell |
1,041,300
-203,200
| -16% | -$22.9M | 0.02% | 635 |
|
|
2025
Q1 | $139M | Buy |
1,244,500
+300,300
| +32% | +$32M | 0.02% | 521 |
|
|
2024
Q4 | $91.9M | Buy |
944,200
+406,200
| +76% | +$43.3M | 0.01% | 769 |
|
|
2024
Q3 | $61.9M | Buy |
538,000
+191,100
| +55% | +$21.7M | 0.01% | 938 |
|
|
2024
Q2 | $36.9M | Sell |
346,900
-18,900
| -5% | -$1.9M | 0.01% | 1203 |
|
|
2024
Q1 | $35.4M | Sell |
365,800
-265,600
| -42% | -$27.2M | 0.01% | 1276 |
|
|
2023
Q4 | $63.8M | Buy |
631,400
+143,500
| +29% | +$13.9M | 0.01% | 901 |
|
|
2023
Q3 | $49.7M | Sell |
487,900
-44,100
| -8% | -$4.48M | 0.01% | 1010 |
|
|
2023
Q2 | $53.7M | Sell |
532,000
-43,900
| -8% | -$4.39M | 0.01% | 946 |
|
|
2023
Q1 | $53M | Sell |
575,900
-43,000
| -7% | -$3.76M | 0.01% | 915 |
|
|
2022
Q4 | $56.1M | Buy |
618,900
+188,200
| +44% | +$15.9M | 0.01% | 822 |
|
|
2022
Q3 | $32.7M | Buy |
430,700
+144,500
| +50% | +$12M | 0.01% | 1057 |
|
|
2022
Q2 | $24.2M | Sell |
286,200
-39,300
| -12% | -$3.45M | 0.01% | 1306 |
|
|
2022
Q1 | $28.6M | Buy |
325,500
+179,500
| +123% | +$15.5M | ﹤0.01% | 1380 |
|
|
2021
Q4 | $12.8M | Sell |
146,000
-336,600
| -70% | -$27.9M | ﹤0.01% | 2382 |
|
|
2021
Q3 | $39.5M | Buy |
482,600
+306,400
| +174% | +$27.6M | 0.01% | 1331 |
|
|
2021
Q2 | $16.1M | Sell |
176,200
-132,700
| -43% | -$11.8M | ﹤0.01% | 2294 |
|
|
2021
Q1 | $26.4M | Sell |
308,900
-56,000
| -15% | -$5.03M | ﹤0.01% | 1583 |
|
|
2020
Q4 | $34.5M | Sell |
364,900
-83,100
| -19% | -$7.26M | 0.01% | 1255 |
|
|
2020
Q3 | $39M | Buy |
448,000
+104,900
| +31% | +$9.09M | 0.01% | 1007 |
|
|
2020
Q2 | $30M | Sell |
343,100
-19,100
| -5% | -$1.65M | 0.01% | 1132 |
|
|
2020
Q1 | $29.9M | Sell |
362,200
-46,600
| -11% | -$4.16M | 0.01% | 943 |
|
|
2019
Q4 | $38.7M | Sell |
408,800
-153,800
| -27% | -$13.8M | 0.01% | 962 |
|
|
2019
Q3 | $48.9M | Sell |
562,600
-800
| -0.1% | -$71.8K | 0.02% | 747 |
|
|
2019
Q2 | $51.4M | Buy |
563,400
+326,808
| +138% | +$27.7M | 0.02% | 674 |
|
|
2019
Q1 | $20.4M | Sell |
236,592
-4,799
| -2% | -$385K | 0.01% | 1175 |
|
|
2018
Q4 | $18.6M | Sell |
241,391
-37,609
| -13% | -$2.93M | 0.01% | 1124 |
|
|
2018
Q3 | $21.5M | Buy |
279,000
+110,372
| +65% | +$8.16M | 0.01% | 1270 |
|
|
2018
Q2 | $11.4M | Buy |
168,628
+106,132
| +170% | +$7.32M | ﹤0.01% | 1808 |
|
|
2018
Q1 | $4.53M | Buy |
62,496
+4,129
| +7% | +$314K | ﹤0.01% | 2672 |
|
|
2017
Q4 | $4.39M | Sell |
58,367
-5,133
| -8% | -$387K | ﹤0.01% | 2689 |
|
|
2017
Q3 | $4.88M | Sell |
63,500
-176,663
| -74% | -$13.3M | ﹤0.01% | 2526 |
|
|
2017
Q2 | $18M | Buy |
240,163
+44,193
| +23% | +$3.13M | 0.01% | 1231 |
|
|
2017
Q1 | $13M | Sell |
195,970
-14,508
| -7% | -$967K | 0.01% | 1394 |
|
|
2016
Q4 | $13.7M | Buy |
210,478
+120,417
| +134% | +$7.81M | 0.01% | 1299 |
|
|
2016
Q3 | $6.37M | Sell |
90,061
-26,003
| -22% | -$1.89M | ﹤0.01% | 1963 |
|
|
2016
Q2 | $8.58M | Sell |
116,064
-25,222
| -18% | -$1.74M | ﹤0.01% | 1578 |
|
|
2016
Q1 | $9.17M | Sell |
141,286
-9,932
| -7% | -$676K | ﹤0.01% | 1637 |
|
|
2015
Q4 | $11.7M | Buy |
151,218
+102,337
| +209% | +$8.13M | 0.01% | 1617 |
|
|
2015
Q3 | $4.03M | Sell |
48,881
-72,540
| -60% | -$6.46M | ﹤0.01% | 3000 |
|
|
2015
Q2 | $10.7M | Buy |
121,421
+65,175
| +116% | +$5.98M | ﹤0.01% | 1917 |
|
|
2015
Q1 | $4.97M | Sell |
56,246
-18,861
| -25% | -$1.67M | ﹤0.01% | 2755 |
|
|
2014
Q4 | $6.24M | Buy |
75,107
+21,427
| +40% | +$1.78M | ﹤0.01% | 2577 |
|
|
2014
Q3 | $4.53M | Sell |
53,680
-1,674
| -3% | -$135K | ﹤0.01% | 3170 |
|
|
2014
Q2 | $4.49M | Sell |
55,354
-31,471
| -36% | -$2.48M | ﹤0.01% | 3266 |
|
|
2014
Q1 | $6.62M | Sell |
86,825
-131,353
| -60% | -$9.57M | ﹤0.01% | 2518 |
|
|
2013
Q4 | $15.7M | Sell |
218,178
-22,878
| -9% | -$1.59M | 0.01% | 1609 |
|
|
2013
Q3 | $16.6M | Buy |
241,056
+67,183
| +39% | +$4.44M | 0.01% | 1369 |
|
|
2013
Q2 | $11M | Buy |
+173,873
| New | +$11.3M | 0.01% | 1682 |
|
Other funds holding NVS
Susquehanna International Group's NVS Position: Q1 2026 in Review
Susquehanna International Group reduced its Novartis (NVS) stake by 37% in Q1 2026, selling an estimated $5.41M and leaving 60,281 shares worth $9.21M. The position accounts for ﹤0.01% of the portfolio, ranked #3238.
Susquehanna International Group first reported a position in NVS in Q2 2013 and has held it in 34 quarters since. The position peaked at $32.2M in Q4 2024. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Susquehanna International Group held 60,281 shares of Novartis worth $9.21M as of Q1 2026.
- Susquehanna International Group sold 35,284 Novartis shares in Q1 2026, an estimated $5.41M.
- Novartis made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3238 holding.
- Susquehanna International Group first reported a position in Novartis in Q2 2013 and has held it in 34 quarters since.
- Susquehanna International Group's Novartis position peaked at $32.2M in Q4 2024.
- 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.